180 Life Sciences将以1比19的比例对其已发行普通股进行反向股票分割

The Reverse Stock Split is expected to become effective on February 28, 2024 at 12:01 p.m. Eastern Time, with shares expected to begin trading on the Nasdaq Capital Market, on a split-adjusted, at market open on February 28, 2024. The Reverse Stock Split is part of the Company's plan to regain compliance with the minimum bid price requirement of $1.00 per share required to maintain continued listing on The Nasdaq Capital Market, among other benefits.